{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(10)"],"submitter":["Ma J"],"pubmed_abstract":["Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapies for these two stages of the HBV-caused detrimental disease. Recently, short hairpin RNA (shRNA) has emerged as a potential therapy for virus-infected disease and cancer. Here, we have generated a shRNA, pGenesil-siHBV4, which effectively inhibits HBV replication in the human hepatoma cell line HepG2.2.15. The inhibitory effects of pGenesil-siHBV4 are manifested by the decrease of both the HBV mRNA level and the protein levels of the secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg"],"journal":["PloS one"],"pagination":["e46096"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3477153"],"repository":["biostudies-literature"],"pubmed_title":["Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs."],"pmcid":["PMC3477153"],"pubmed_authors":["Liu H","Huang C","Yuan L","Zhu H","Yao X","Shen G","Sun L","Ning Q","Shi C","Zhou C","Ma J","Lei P","Wu X"],"additional_accession":[]},"is_claimable":false,"name":"Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs.","description":"Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapies for these two stages of the HBV-caused detrimental disease. Recently, short hairpin RNA (shRNA) has emerged as a potential therapy for virus-infected disease and cancer. Here, we have generated a shRNA, pGenesil-siHBV4, which effectively inhibits HBV replication in the human hepatoma cell line HepG2.2.15. The inhibitory effects of pGenesil-siHBV4 are manifested by the decrease of both the HBV mRNA level and the protein levels of the secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012","modification":"2026-04-07T20:47:38.675Z","creation":"2019-03-26T23:19:05Z"},"accession":"S-EPMC3477153","cross_references":{"pubmed":["23094023"],"doi":["10.1371/journal.pone.0046096"]}}